Range
2.55 - 2.8
Vol / Avg.
131.3K/330.9K
Div / Yield
-
52 Wk
2.35 - 62
Mkt Cap
36.3M
Payout Ratio
-
Open
2.74
P/E
-
EPS
4.8
Shares
14M
Outstanding
14M
Total Float
-
Sector: Health Care.Industry: Pharmaceuticals
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS-0.009
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BVXVBiondVax Pharmaceuticals-4.76%36.3M

BiondVax Pharmaceuticals Company Questions & Answers

Q

How do I buy BiondVax Pharmaceuticals (BVXV) stock?

A

You can purchase shares of BiondVax Pharmaceuticals (NASDAQ: BVXV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BiondVax Pharmaceuticals's (BVXV) main competitors?

A

Other companies in BiondVax Pharmaceuticals’s space includes: Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX) and Pulmatrix (NASDAQ:PULM).

Q

What is the target price for BiondVax Pharmaceuticals?

A

The latest price target for BiondVax Pharmaceuticals (NASDAQ: BVXV) was reported by Aegis Capital on 2015-06-26. The analyst firm set a price target for 15.00 expecting BVXV to rise to within 12 months (a possible 476.92% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is BiondVax Pharmaceuticals (BVXV) stock ?

A

The stock price for BiondVax Pharmaceuticals (NASDAQ: BVXV) is $2.6 last updated Thu May 13 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next BiondVax Pharmaceuticals (BVXV) dividend?

A

There are no upcoming dividends for BiondVax Pharmaceuticals.

Q

When is BiondVax Pharmaceuticals (NASDAQ:BVXV) reporting earnings?

A
BiondVax Pharmaceuticals’s Q4 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for BVXV?

A

There is no upcoming split for BiondVax Pharmaceuticals.